Journal article
Antiviral agents for influenza
Abstract
The economic burden of influenza-related illness has been estimated to be $US71.3–166 billion in the US, the majority of which is attributable to indirect costs as a result of lost productivity. There are currently four antiviral drugs available for the treatment of influenza: two ion channel blockers, amantadine and rimantadine; and two neuraminidase inhibitors, zanamivir and oseltamivir. The objective of this paper was to review the studies …
Authors
Lynd LD; Goeree R; O’Brien BJ
Journal
PharmacoEconomics, Vol. 23, No. 11, pp. 1083–1106
Publisher
Springer Nature
Publication Date
11 2005
DOI
10.2165/00019053-200523110-00003
ISSN
1170-7690